Skip to main content
Bambusa Therapeutics, Inc. (BBTX)
NASDAQ: BBTX · Real-Time Price · USD
17.50
+0.34 (1.98%)
Nov 12, 2026, 9:36 AM EST - Market open

Bambusa Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash & Equivalents
46.5350.649.36
Short-Term Investments
24.9439.98-
Cash & Short-Term Investments
71.4890.639.36
Cash Growth
-868.03%-
Other Receivables
1.231.880.03
Receivables
1.231.880.03
Prepaid Expenses
2.231.040.28
Other Current Assets
0.370.580.09
Total Current Assets
75.394.139.76
Other Long-Term Assets
0.451.58-
Total Assets
77.595.719.76

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Accounts Payable
1.611.910.01
Accrued Expenses
10.617.749.3
Total Current Liabilities
12.229.659.32
Total Liabilities
12.229.659.32

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Additional Paid-In Capital
6.255.60.19
Retained Earnings
-77.19-54.83-13.74
Comprehensive Income & Other
-0.020.06-
Total Common Equity
-70.96-49.17-13.55
Shareholders' Equity
65.2786.070.45
Total Liabilities & Equity
77.595.719.76

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Net Cash (Debt)
71.4890.639.36
Net Cash Growth
-868.03%-
Net Cash Per Share
8.9221.62-
Filing Date Shares Outstanding
8.018.01-
Total Common Shares Outstanding
8.018.01-
Working Capital
63.0884.480.45
Book Value Per Share
-8.86-6.14-
Tangible Book Value
-70.96-49.17-13.55
Tangible Book Value Per Share
-8.86-6.14-
SEC Filings: 10-K · 10-Q